Update on pediatric autoimmune encephalitis-associated epilepsy

Celia Greenlaw; Coral M. Stredny

doi:10.1097/wco.0000000000001472

February 24, 2026Current Opinion in Neurology

Update on pediatric autoimmune encephalitis-associated epilepsy

View at Publisher

Ask AI

Bookmark

Share

Key Points

To improve outcomes for pediatric patients with autoimmune encephalitis-associated epilepsy by identifying key factors.
Analysis of morbidity associated with pediatric autoimmune encephalitis-associated epilepsy.
Investigation of risk factors and biomarkers relevant to the condition.
Development of targeted therapeutic approaches based on findings.
Identification of significant morbidity rates in affected patients.
Discovery of potential risk factors and biomarkers that contribute to disease outcomes.

Implication

Research reveals risk factors and biomarkers in pediatric epilepsy, suggesting new targeted therapeutic approaches.

Abstract

Pediatric AEAE is associated with significant morbidity, and research is underway to improve outcomes for these patients by determining risk factors, identifying biomarkers, and developing targeted therapeutic approaches.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Greenlaw et al. (2026) studied this question.

synapsesocial.com/papers/699f95a81bc9fecf3dab3bdd https://doi.org/10.1097/wco.0000000000001472

View at Publisher

Ask AI

Bookmark

Share

Update on pediatric autoimmune encephalitis-associated epilepsy

Key Points

Implication

Abstract

Discussion

Cite This Study

Update on pediatric autoimmune encephalitis-associated epilepsy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

More related papers

More from Current Opinion in Neurology

Keep reading

More related papers

More from Current Opinion in Neurology